PE20151806A1 - Composiciones nutricionales que contienen treonato de magnesio y uso del mismo - Google Patents

Composiciones nutricionales que contienen treonato de magnesio y uso del mismo

Info

Publication number
PE20151806A1
PE20151806A1 PE2015001303A PE2015001303A PE20151806A1 PE 20151806 A1 PE20151806 A1 PE 20151806A1 PE 2015001303 A PE2015001303 A PE 2015001303A PE 2015001303 A PE2015001303 A PE 2015001303A PE 20151806 A1 PE20151806 A1 PE 20151806A1
Authority
PE
Peru
Prior art keywords
magnesium threonate
same
compositions containing
containing magnesium
nutritional compositions
Prior art date
Application number
PE2015001303A
Other languages
English (en)
Inventor
Brian Berg
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49887325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20151806(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20151806A1 publication Critical patent/PE20151806A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente divulgacion se refiere a la(s) composicion(es) nutricional(es) que comprende una fuente de hidratos de carbono, una fuente de proteinas, una fuente de grasa y treonato de magnesio. El treonato de magnesio puede proporcionar beneficios para la salud neurologica cuando son consumidos. La descripcion ademas se refiere a los metodos de promocion de la salud neurologica proporcionando una composicion nutricional que comprende treonato de magnesio. Asimismo, la divulgacion se refiere a metodos para promover la tolerancia gastrointestinal en un sujeto pediatrico proporcionando una composicion nutricional que comprende treonato de magnesio
PE2015001303A 2013-01-11 2013-12-12 Composiciones nutricionales que contienen treonato de magnesio y uso del mismo PE20151806A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/739,813 US9301966B2 (en) 2013-01-11 2013-01-11 Nutritional compositions containing magnesium threonate and uses thereof

Publications (1)

Publication Number Publication Date
PE20151806A1 true PE20151806A1 (es) 2015-12-17

Family

ID=49887325

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001303A PE20151806A1 (es) 2013-01-11 2013-12-12 Composiciones nutricionales que contienen treonato de magnesio y uso del mismo

Country Status (18)

Country Link
US (1) US9301966B2 (es)
EP (1) EP2943081B1 (es)
CN (2) CN104883911A (es)
AU (1) AU2013372899B2 (es)
BR (1) BR112015011931A2 (es)
CA (1) CA2897776A1 (es)
EC (1) ECSP15034601A (es)
ES (1) ES2649715T3 (es)
HK (1) HK1214091A1 (es)
MX (1) MX366527B (es)
MY (1) MY170033A (es)
NO (1) NO2967044T3 (es)
PE (1) PE20151806A1 (es)
PH (1) PH12015501688A1 (es)
PL (1) PL2943081T3 (es)
RU (1) RU2015122495A (es)
SG (1) SG11201503753XA (es)
WO (1) WO2014109863A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US10525016B2 (en) * 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
WO2017102717A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional composition and infant formula for promoting de novo myelination
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
CN106333366A (zh) * 2016-09-28 2017-01-18 张家港威胜生物医药有限公司 一种具有抗疲劳作用的组合物及其制备方法与用途
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
WO2018200885A1 (en) * 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use
CN109845877B (zh) * 2017-11-30 2022-07-12 内蒙古伊利实业集团股份有限公司 一种水解蛋白脱苦组合物及其产品、制备和应用
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2022157798A1 (en) * 2021-01-22 2022-07-28 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for treating neurocognitive disorders
CN115868628B (zh) * 2022-10-11 2024-01-26 泓博元生命科技（深圳）有限公司 减肥组合物
CN115894216B (zh) * 2022-12-19 2024-08-06 浦拉司科技（上海）有限责任公司 一种l-苏糖酸镁的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681174C (en) 2007-03-22 2020-06-02 Guosong Liu Magnesium compositions and uses thereof
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
WO2010047581A1 (en) * 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition
EP2251031A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
WO2011003045A1 (en) * 2009-07-01 2011-01-06 Magceutics, Inc. Slow release magnesium composition and uses thereof
US8648036B2 (en) 2010-12-29 2014-02-11 Mead Johnson Nutrition Company Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US20130095204A1 (en) 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions

Also Published As

Publication number Publication date
HK1214091A1 (zh) 2016-07-22
BR112015011931A2 (pt) 2017-07-11
CN110101079A (zh) 2019-08-09
PH12015501688B1 (en) 2015-10-19
MX2015008583A (es) 2015-09-04
AU2013372899B2 (en) 2016-12-08
EP2943081B1 (en) 2017-10-04
SG11201503753XA (en) 2015-06-29
RU2015122495A (ru) 2017-02-17
US20140200176A1 (en) 2014-07-17
WO2014109863A1 (en) 2014-07-17
ES2649715T3 (es) 2018-01-15
ECSP15034601A (es) 2015-11-30
MY170033A (en) 2019-06-26
PL2943081T3 (pl) 2018-03-30
US9301966B2 (en) 2016-04-05
PH12015501688A1 (en) 2015-10-19
MX366527B (es) 2019-07-12
EP2943081A1 (en) 2015-11-18
CN104883911A (zh) 2015-09-02
AU2013372899A1 (en) 2015-05-28
NO2967044T3 (es) 2018-06-02
CA2897776A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
PE20151806A1 (es) Composiciones nutricionales que contienen treonato de magnesio y uso del mismo
NZ732700A (en) Microencapsulated cannabinoid compositions
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
CR20130411A (es) Composiciones de puré que tienen proporciones de carbohidrato específicas y los métodos para utilizar las mismas
BR112013021372A2 (pt) germoplasma de canola exibindo atributos na composição da semente para intensificar o valor nutricional do farelo de canola tendo traços de omega-9
UY34751A (es) ?composición de pienso para reducir la metanogénesis en rumiantes?
EA201491323A1 (ru) Способ кормления
BR112015024040A2 (pt) preparação alergênica
CO6771418A2 (es) Uso de composiciones nutricionales que incluyen lactoferrina para estimular las células del sistema inmunológico
UA116654C2 (uk) Похідні пурину як агоністи канабіноїдного рецептора св2
AR098034A1 (es) Composición alimenticia para animales rumiantes que contiene carbohidratos y método de preparación
EA201592085A1 (ru) Применение жирной кислоты таллового масла
ECSP13012799A (es) Uso de composiciones nutricionales que incluyen lactoferrinas para mejorar la resistencia a enfermedades y condiciones
BR112015027824A2 (pt) composições de vitamina e em pó
AR113514A1 (es) Composiciones y métodos para mejorar la utilización del fósforo y el calcio en la dieta de los animales
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
PH12015501816A1 (en) Anti-regurgitation nutritional composition
CL2014003185A1 (es) Preformulacion de baja viscosidad que comprende pasireotida, agonista del receptor de somatostatina; proceso de preparacion de la preformulacion; kit farmaceutico; uso para tratar enfermedad de cushing o acromegalia.
AR098035A1 (es) Composición alimenticia para animales rumiantes que contiene proteínas y método de preparación
PH12015502242A1 (en) Lutein composition suitable for infant food formulations
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional
HK1208149A1 (en) Use of patchouli extract in the preparation of compositions with an anti-microorganism effect
IT201700115753A1 (it) Integratore per attenuare i disturbi nella donna causati dall’invecchiamento
TH161437B (th) องค์ประกอบทางโภชนาการที่มีแมกนีเซียมธรีโอเนตและการใช้ของมัน
TH161437A (th) องค์ประกอบทางโภชนาการที่มีแมกนีเซียมธรีโอเนตและการใช้ของมัน

Legal Events

Date Code Title Description
FA Abandonment or withdrawal